Reuters logo
9 个月前
BRIEF-Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes
2016年11月22日 / 早上6点26分 / 9 个月前

BRIEF-Zealand Pharma: US FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes

Nov 22 (Reuters) - Zealand Pharma A/S :

* Said on Tuesday, U.S. FDA approves Soliqua 100/33 for treatment of adults with type 2 diabetes

* FDA approval triggers a $25 million milestone payment and double-digit percentage royalties of net sales of Soliqua to Zealand

* Sanofi plans to make Soliqua available in U.S. retail pharmacies in Jan. 2017

Source text for Eikon:

Further company coverage:

Gdynia Newsroom

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below